97例新冠肺炎中西医结合治疗经验总结

Analysis of 97 Cases of COVID-19 Treated with Integrated Chinese and Western Medicine

随着新冠肺炎(COVID-19)在全世界范围内的肆虐,我国已将该病纳入传染病防治法规定的乙类传染病,并实行甲类管理。其传染迅速、波及面广,对各族人民的生命健康构成了严重威胁。疫情爆发后,我院根据《新型冠状病毒肺炎诊疗方案(试行)》第七版及第八版指南,分析97例COVID-19患者舌苔及疗效,得出新疆此次疫情中医特点以“湿毒疫”为主,同时深入分析清肺排毒汤组方,该方的理法方药可以应对“湿毒疫”的病因病机,对新型冠状病毒具有特异的抗病毒作用。我院发挥中西医结合的独特优势,在本次抗击疫情工作中取得了良好的效果。本研究对清肺排毒汤在临床中的应用做一总结,以期为临床提供借鉴和参考。

With COVID-19 ravages around the world,COVID-19 was included as a Class B Infectious Disease in China under the law on the prevention and treatment of infectious diseases,and implemented class A management.It posed a serious threat to the life and health of people.After the outbreak of the COVID-19,our hospital according to the seventh and eighth edition of COVID-19 therapeutic regimen,and analyzed the tongue coating and curative effect of 97 cases of COVID-19 patients.It is concluded that the COVID-19 outbreak in Xinjiang was characterized as"wet poison plague".In-depth analysis of"Qingfei paidu decoction"were carried out at the same time.The ingredient of the decoction can meet the etiology and pathogenesis of"wet poison plague"with specific antiviral effects to coronavirus.With the unique advantage of integrated traditional Chinese and western medicine,our hospital has obtained good effect.This article summarized the clinical application of Qingfei paidu decoction to provide reference for clinical practice.